Luca Di Leo

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Intellectual Disability

Basal Cell Carcinoma

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Luca Di Leo, Chiara Pagliuca, Ali Kishk, Salvatore Rizza, Christina Tsiavou, Chiara Pecorari, Christina Dahl, Maria Pires Pacheco, Rikke Tholstrup, Jonathan Richard Brewer, Pietro Berico, Eva Hernando, Francesco Cecconi, Robert Ballotti, Corine Bertolotto, Giuseppe Filomeni, Morten Frier Gjerstorff, Thomas Sauter, Penny Lovat, Per Guldberg, Daniela De Zio
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma. Proceedings of the National Academy of Sciences of the United States of America 121 (25) (2024)
Tamara Bintener, Maria Pires Pacheco, Demetra Philippidou, Christiane Margue, Ali Kishk, Greta Del Mistro, Luca Di Leo, Maria Moscardó Garcia, Rashi Halder, Lasse Sinkkonen, Daniela De Zio, Stephanie Kreis, Dagmar Kulms, Thomas Sauter
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma. Cell death & disease 14 (7) (2023)
Chiara Pagliuca, Luca Di Leo, Daniela De Zio
New Insights into the Phenotype Switching of Melanoma. Cancers 14 (24) (2022)
Matteo Tiberti, Luca Di Leo, Mette Vixø Vistesen, Rikke Sofie Kuhre, Francesco Cecconi, Daniela De Zio, Elena Papaleo
The Cancermuts software package for the prioritization of missense cancer variants: a case study of AMBRA1 in melanoma. Cell death & disease 13 (10) (2022)
Chiara Pagliuca, Luca Di Leo, Daniela De Zio
New Insights into the Phenotype Switching of Melanoma. Cancers 14 (24) (2022)
Emiliano Maiani, Giacomo Milletti, Francesca Nazio, Søs Grønbæk Holdgaard, Jirina Bartkova, Salvatore Rizza, Valentina Cianfanelli, Mar Lorente, Daniele Simoneschi, Miriam Di Marco, Pasquale D Acunzo, Luca Di Leo, Rikke Rasmussen, Costanza Montagna, Marilena Raciti, Cristiano De Stefanis, Estibaliz Gabicagogeascoa, Gergely Rona, Nélida Salvador, Emanuela Pupo, Joanna Maria Merchut-Maya, Colin J Daniel, Marianna Carinci, Valeriana Cesarini, Alfie O'sullivan, Yeon-Tae Jeong, Matteo Bordi, Francesco Russo, Silvia Campello, Angela Gallo, Giuseppe Filomeni, Letizia Lanzetti, Rosalie C Sears, Petra Hamerlik, Armando Bartolazzi, Robert Edward Hynds, David R Pearce, Charles Swanton, Michele Pagano, Guillermo Velasco, Elena Papaleo, Daniela De Zio, Apolinar Maya-Mendoza, Franco Locatelli, Jiri Bartek, Francesco Cecconi
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity. Nature 592 (7856) (2021)
Luca Di Leo, Valérie Bodemeyer, Francesca M Bosisio, Giuseppina Claps, Marco Carretta, Salvatore Rizza, Fiorella Faienza, Alex Frias, Shawez Khan, Matteo Bordi, Maria P Pacheco, Julie S Di Martino, Jose J Bravo-Cordero, Colin J Daniel, Rosalie C Sears, Marco Donia, Daniel H Madsen, Per Guldberg, Giuseppe Filomeni, Thomas Sauter, Caroline Robert, Daniela De Zio, Francesco Cecconi
Loss of Ambra1 promotes melanoma growth and invasion. Nature communications 12 (1) (2021)